Immunogenicity and safety of a combined DTaP–IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4

Immunogenicity and safety of a combined DTaP–IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4–6 years

Published:2006-08 Issue:35-36 Volume:24 Page:6163-6171
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Black Steven,Friedland Leonard R.,Schuind Anne,Howe Barbara

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference32 articles.

1. Child vaccination policies in Europe: a report from the Summits of independent European vaccination experts;Schmitt;Lancet Infect Dis,2003

2. Centers for Disease Control and Prevention. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR 2002;51(RR-2):1–35.

3. Pertussis immunisation in Europe—the situation in late 1999;Therre;Euro Surveill,2000

4. Centers for Disease Control and Prevention. Pertussis, United States, 1997–2000. MMWR 2002;51:73–6.

5. Pertussis of adults and infants;von Konig;Lancet Infect Dis,2002

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine, and measles-mumps-rubella vaccine to healthy infants aged 18 months in China;International Journal of Infectious Diseases;2023-12

2. Combination Vaccines;Plotkin's Vaccines;2023

3. Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model;Vaccines;2021-12-30

4. Prevention of measles, mumps and rubella: 40 years of global experience with M-M-R_II;Human Vaccines & Immunotherapeutics;2021-12-02

5. Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children;Human Vaccines & Immunotherapeutics;2019-03-19